Aaron Fullerton
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 3
-
- Cell death mechanisms and regulation 2
- Co-authors
- Robert A. Roth (7 shared papers)Patricia E. Ganey (7 shared papers)William R. Proctor (4 shared papers)Kevin M. Beggs (2 shared papers)Norman Peterson (1 shared paper)Prathap Kumar S. Mahalingaiah (1 shared paper)Matteo Piazza (1 shared paper)Kazuhisa Miyakawa (1 shared paper)
- Journals
- Toxicological Sciences (4 papers)Toxicology and Applied Pharmacology (2 papers)Hepatology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)PLoS Computational Biology (1 paper)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Aaron Fullerton
23 papers receiving 306 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 143
- Hepatology 46
- Immunology 50
- Oncology 59
- Biological Psychiatry 5
Countries citing papers authored by Aaron Fullerton
This map shows the geographic impact of Aaron Fullerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Fullerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Fullerton more than expected).
Fields of papers citing papers by Aaron Fullerton
This network shows the impact of papers produced by Aaron Fullerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Fullerton. The network helps show where Aaron Fullerton may publish in the future.
Co-authors
The 25 scholars most cited alongside Aaron Fullerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 54 | |
| 2 | 2013 | 30 | |
| 3 | 2011 | 29 | |
| 4 | 2020 | 26 | |
| 5 | 2009 | 26 | |
| 6 | 2015 | 25 | |
| 7 | 2015 | 19 | |
| 8 | 2014 | 14 | |
| 9 | 2013 | 14 | |
| 10 | 2012 | 12 | |
| 11 | 2018 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2025 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2006 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 2020 | 4 |
About Aaron Fullerton
Aaron Fullerton is a scholar working on Pharmacology, Molecular Biology, Immunology, Oncology and Biomedical Engineering, having authored 24 papers that have together received 316 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), 3D Printing in Biomedical Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Immune Cell Function and Interaction (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Immune Response and Inflammation (3 papers), Liver physiology and pathology (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Pharmacology (143 citations), Hepatology (46 citations), Immunology (50 citations), Oncology (59 citations) and Biological Psychiatry (5 citations). Aaron Fullerton has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Robert A. Roth, Patricia E. Ganey, William R. Proctor, Kevin M. Beggs, Norman Peterson, Prathap Kumar S. Mahalingaiah, Matteo Piazza, Kazuhisa Miyakawa, Lance R. Pohl and Michael A. Scott. Their work appears in journals such as Toxicological Sciences, Toxicology and Applied Pharmacology, Hepatology, Cancer Chemotherapy and Pharmacology and PLoS Computational Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.